Table 2.
EPA, DHA and their sum as a percentage of total fatty acids in red blood cells and plasma.
| O-3 + TRAIN (n = 14) | TRAIN (n = 12) | rANOVA | |||||
|---|---|---|---|---|---|---|---|
| PRE | POST | Δ (CI) | PRE | POST | Δ (CI) | Group x time | |
| DHA (% in red blood cells) | 4.68 ± 1.03 | 6.69 ± 0.76* | 2.01 (1.66;2.35) | 4.42 ± 1.11 | 4.68 ± 1.01 | 0.2 (− 0.28;0.68) | < 0.01 |
| EPA (% in red blood cells) | 1.11 ± 0.39 | 4.88 ± 1.11* | 3.77 (3.14;4.41) | 1.16 ± 0.3 | 1.18 ± 0.44 | − 0.01 (− 0.28;0.26) | < 0.01 |
| DHA (% in plasma) | 2.38 ± 0.5 | 4.01 ± 0.5* | 1.64 (1.32;1.96) | 2.18 ± 0.69 | 2.2 ± 0.78 | − 0.09 (− 0.59;0.4) | < 0.01 |
| EPA (% in plasma) | 1.17 ± 0.51 | 5.15 ± 1.53* | 3.94 (3.05;4.83) | 1.19 ± 0.38 | 1.04 ± 0.46 | -0.21 (− 0.61;0.2) | < 0.01 |
| DHA + EPA (% in red blood cells) | 5.79 ± 1.35 | 11.57 ± 1.7* | 5.78 (4.9;6.66) | 5.67 ± 1.37 | 5.86 ± 1.39 | 0.19 (− 0.5;0.88) | < 0.01 |
| DHA + EPA (% in plasma) | 3.59 ± 0.97 | 9.16 ± 1.97* | 5.58 (4.43;6.73) | 3.38 ± 0.97 | 3.08 ± 1.14 | − 0.3 (− 1.16;0.56) | < 0.01 |
Values are presented as mean ± SD; EPA—eicosapentaenoic acid; DHA—docosahexaenoic acid. Δ—POST to PRE changes; CI—confidence interval of changes; rANOVA—repeated measurement analysis of variance*-statistically significant difference compared to PRE; p < 0.05.
Data are presented as mean ± SD *statistically significant difference in groups (Δ) with a trend of higher percentages in the O3 + TRAIN group and lower percentages in the TRAIN group.